Navigation Links
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
Date:11/27/2012

BOSTON, Nov. 27, 2012 /PRNewswire/ -- Rhythm announced today that the company has raised an additional $8 million to complete a $33 million Series B financing. The additional $8 million comes from new investor, Pfizer Venture Investments, the venture capital arm of Pfizer. Pfizer joins existing investors MPM Capital, New Enterprise Associates, Third Rock Ventures, and Ipsen, which all participated in a first closing of the Series B financing earlier this year.

Rhythm will use the proceeds to further develop its small-peptide therapeutics for metabolic diseases. RM-131 is a ghrelin agonist currently in Phase 2 clinical trials for diabetic gastroparesis and GI functional disorders. RM-493 is a melanocortin 4 receptor (MC4R) agonist that is completing Phase 1 clinical trials for the treatment of obesity and diabetes. This additional financing brings the total capital raised by Rhythm to $73 million.

"We are excited to have the support of Pfizer Ventures as we advance both metabolic programs through Phase 2 trials," said Bart Henderson, Co-Founder and President of Rhythm. "The Pfizer team has deep commercial and development experience that we intend to leverage as we expand the clinical trial program for these two important new therapeutics."

"The obesity and diabetes epidemics represent one of the largest medical challenges confronting society today," said Dr. Barbara Dalton, Vice President Venture Capital, Pfizer Venture Investments. "Rhythm's metabolic programs are compelling because of the initial proof-of-concept data from ongoing clinical programs, along with the fact that peptide therapeutics have delivered high success rates in clinical development. We are pleased to help Rhythm capitalize on its opportunities."

About Pfizer Venture Investments
Pfizer Venture Investments (PVI), the venture capital arm of Pfizer Inc., was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. As part
'/>"/>

SOURCE Rhythm
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
2. Rap music powers rhythmic action of medical sensor
3. Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis
4. Rhythmic firing of nerve cells involved in bodys movements
5. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
6. UV Flu Technologies Expands Its International Footprint
7. Nabsys Expands Leadership Team to Prepare for Commercialization of Novel DNA Positional Sequencing Technology
8. Ansell Limited Expands Korean Presence
9. Premier Research Expands Salt Lake City and Phoenix Testing Facilities Adding 50% Capacity
10. Groundbreaking National Program to Reverse Obesity Expands to 50 Locations
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Savoury Systems International (SSI), a leader in ... Southeastern USA Sales Broker. Braddy’s new role will allow ... Southeast. , In 2004 Braddy founded Southeastern ... food processors and industrial manufacturers. Braddy has worked ... and has over 25 years of sales management experience. ...
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 Smarter ... outdoor security solutions, today announced that Genzyme, a Sanofi ... units of Door Detective® CL for a multi-use facility ... installed in four other Genzyme buildings, this latest order ... with the tailgate detection device improving doorway ...
(Date:5/21/2013)... As the R&D sector becomes ... the industry to deliver better products, faster. Collaborations ... companies often means turning big ideas into reality, ... collaboration with Sensidose AB and Recipharm, is one ... to market sooner. The partnership resulted in the ...
(Date:5/21/2013)... Emerson Resources Inc. , a ... Signorino, the Company’s Chief Executive Officer and Chairman of ... years of service. As part of Emerson Resources’ planned ... been named as Dr. Signorino’s successor. , Dr. ... having made a significant contribution to the field during ...
Breaking Biology Technology:Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3
... all the forms of cancer, ovarian cancer is ... stages. The federal government is providing incentives for companies to ... is one of the beneficiaries. , , NeoClone Biotechnology International ... research, has landed a $750,000 federal contract to continue research ...
... loss in 2007, Hutchinson Technology , a Minnesota-based computer ... manufacturing plant, according to a report in the Chippewa ... are part of an overall workforce reduction of 500 employees, ... Sioux Falls, S.D. The company is headquartered in Hutchinson, Minn. ...
... - The June 30 deadline is approaching for ... $223.9 million in benefits from a class action ... attorneys lawyers involved in the court-approved settlement. ... Wisconsin's antitrust and unfair competition laws. , ,The ...
Cached Biology Technology:June 30 is deadline to claim up to $223.9M in Microsoft settlement 2
(Date:5/20/2013)... about the effect of physical education (PE) on child ... that increasing the amount of time that elementary schoolchildren ... , The study represents some of the first evidence ... and is forthcoming in the Journal of Health ... study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , ...
(Date:5/20/2013)... new study conducted at the University of Bristol and ... Biology sheds light on how the brain and ... from Bristol,s School of Earth Sciences, together with Tom ... the brains of 150 million year old dinosaurs. , ... dinosaur Dysalotosaurus lettowvorbecki : a very young (juvenile) ...
(Date:5/18/2013)... Research Foundation is honored to announce the first AGA-Caroline ... which will support Andrew D. Rhim, MD, from the ... Philadelphia, as he furthers his research on the role ... , "The AGA Research Foundation is humbled to issue ... AGA Legacy Society members," said Nicholas F. LaRusso, MD, ...
Breaking Biology News(10 mins):Gym class reduces probability of obesity, study finds for first time 2Fossil brain teaser 2AGA Research Foundation grant furthers digestive cancer research 2
... vitamin D, as well as the nutrients betaine and methionine, ... new research conducted by Tufts Medical Center scientists. Their study ... Registry also found that the more a person smoked, the ... Dietary Betaine, Methionine, and Vitamin D in Monozygotic Twins with ...
... of Colorado Boulder is involved with five different space ... to new bone-loss treatments to an experiment to improve ... July 8 on the last of NASA,s 135 space ... pharmaceutical companies Amgen and UCB, will test an antibody ...
... A natural form of vitamin E called alpha-tocotrienol can trigger ... from nerve cells, preventing those cells from dying after a ... three mechanisms identified so far that this form of vitamin ... that this natural substance might be more potent than drugs ...
Cached Biology News:Twin study shows lifestyle, diet can significantly influence course of macular degeneration 2Final space shuttle to carry 5 CU-Boulder-built payloads 2Final space shuttle to carry 5 CU-Boulder-built payloads 3Final space shuttle to carry 5 CU-Boulder-built payloads 4'Gifted' natural vitamin E tocotrienol protects brain against stroke in 3 ways 2'Gifted' natural vitamin E tocotrienol protects brain against stroke in 3 ways 3'Gifted' natural vitamin E tocotrienol protects brain against stroke in 3 ways 4
Vertical Rack (five box vapor phase rack), includes 2.0" (5.1cm) boxes...
... 1-D PAGE Cleavable ICAT ... Targeted Protein ID and ... Gel Electrophoresis (PAGE), isotope-coded ... cleavable-linker technology to facilitate ...
Conjugate Quality Control Evaluation Specificity: Conjugate Quality Control Evaluation ...
Qa-1 (L-12)...
Biology Products: